Investview (INVUP) Cash & Equivalents (2010 - 2026)

Investview has disclosed Cash & Equivalents across 17 years of filings, most recently posting $4.5 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 74.14% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $4.5 million (down 74.14% YoY), while the FY2025 annual figure was $10.0 million, down 55.53% from the prior year.
• Cash & Equivalents declined to $4.5 million in Q1 2026, from $10.0 million in the prior quarter.
• Over the last five years, Cash & Equivalents for INVUP reached as high as $24.9 million in Q1 2022 and fell as low as $4.5 million in Q1 2026.
• The 5-year median for Cash & Equivalents is $20.6 million (2022), against an average of $19.2 million.
• Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 361.37% — and 2026, when it slumped 74.14%.
• A 5-year view of Cash & Equivalents shows it stood at $20.3 million in 2022, then rose by 2.93% to $20.9 million in 2023, then climbed by 7.44% to $22.5 million in 2024, then tumbled by 55.53% to $10.0 million in 2025, then tumbled by 54.72% to $4.5 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $4.5 million, $10.0 million, and $15.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.